UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month ofNovember 2005
Novogen Limited
140 Wicks Road, North Ryde, NSW, 2113, Australia
(Address of principal executive office)
[Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-Fx Form 40-Fo
[Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yeso Noo
[If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2 (b): 82- .1
4 NOVEMBER, 2005
NOVOGEN ANNOUNCEMENT
ISSUED FOR | : | NOVOGEN LIMITED | ||||||
LISTINGS | : | ASX (CODE NRT), NASDAQ (CODE NVGN). | ||||||
FOR FURTHER | ||||||||
INFORMATION : | : | MR CHRISTOPHER NAUGHTON, MANAGING DIRECTOR, NOVOGEN LIMITED | ||||||
TEL (02) 9878 0088 | http://www.novogen.com |
Philip A Johnston
Chairman
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Novogen Limited (Registrant) | ||||
4 November 2005 | By | |||
Ronald Lea Erratt Company Secretary |